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By: Haley Klimecki 
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Abstract 
 Human neutrophils are the most abundant type of white blood cell and provide the 
body with a line of defense against foreign, infectious microorganisms.  Contained within 
the azurophilic granules in the cytoplasm of neutrophils are three serine proteases, 
Human Neutrophil Elastase, Cathepsin G, and Protease 3.  Once a foreign bacterium is 
engulfed by white blood cells, these enzymes attack and degrade the invading body, thus 
killing it (Reeves et al., 2002).  The focus of this research is centered on the production of 
one of the serine proteases, human neutrophil elastase (HNE), and while the importance 
of HNE can be seen, genetic mutations or improper regulation can compromise a 
person’s immunity.  Neutropenia (a low neutrophil count) is one such disease caused by a 
genetic mutation of HNE that results in susceptibility to infection (Li and Horwitz, 2001).  
Additionally, HNE is a powerful enzyme that can attack the elastin of the lung if not 
properly controlled.  Consequently, genetic deficiencies of alpha-1 proteinase inhibitor 
protein in the blood can result in emphysema because active HNE released from 
neutrophils is free to degrade lung tissue (Laurell and Eriksson, 1965).   
 
 Recombinant HNE is not currently available, and the enzyme must be isolated 
from human blood cells, which has inherent hazards.  Additionally, the lack of 
recombinant HNE has prevented studies involving site–directed mutagenesis to study the 
intracellular processing of HNE near its C-terminal end where mutations have been found 
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to result in neutropenia.   Kinetic studies of the full-length HNE might shed some light on 
why its C-terminal region is removed before storage in cytoplasmic granules.  
 
 The HNE DNA sequence was first codon optimized for yeast and commercially 
synthesized.   It was then fused with DNA for eGFP (enhanced green fluorescent protein) 
via an enterokinase cleavage site (D4K).  This DNA construct (eGFP-D4K-HNE) was 
then inserted into the Kluyveromyces lactis (K. lactis) pKLAC1 vector, downstream of 
the alpha mating factor which directs proteins for secretion.  Then, chemically competent 
GG799 cells (a strain of K. lactis) were transformed with the linearized pKLAC1-eGFP-
D4K-HNE insert through a protocol from New England Biolabs.  Theoretically, the gene 
integrates into the yeast genome upon transformation via sequences within the pKLAC1 
vector that are homologous with the LAC4 gene promoter that allows for galactose 
utilization (Colussi 2005).  Acetamide was used as a selectable marker because wild type 
K. lactis cells are not able to use acetamide as a nitrogen source.  The pKLAC1 vector, 
however, contains the Aspergillus nidulans gene acetamidase (amdS) that allows only 
transformants to grow on plates with acetamide as the sole nitrogen source (Read 2007).   
 
 Selected colonies were transferred to both liquid and agar-based synthetic media 
with galactose to induce transcription and translation of the HNE gene to produce the 
eGFP-D4K-HNE fusion, and screened via fluorescence microscopy for production of 
eGFP.  None of the screened colonies tested positive for the presence of the fusion 
protein. 
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Introduction 
The body’s first line of defense against attack by infectious microorganisms is its 
neutrophils, the most abundant type of white blood cell circulating in the blood.  Though 
neutrophils have a short half-life of around seven hours, they are continually produced by 
the bone marrow when an infection arises.  Upon arrival at sites of infection in the body, 
neutrophils engulf invading bacteria by phagocytosis.  After ingestion, the azurophilic 
granules within the cytoplasm of neutrophils release certain proteases that aid in bacterial 
killing and digestion (Reeves, Lu et al. 2002).  One such enzyme is human neutrophil 
elastase (HNE), a serine protease.   HNE is an enzyme that is able to degrade bacterial 
proteins in the killing process, and it is termed an “elastase” because it will also degrade 
elastin which is resistant to other proteases such as trypsin.  While the role of HNE is 
essential for the proper functioning of a person’s immune system, mutations of the 
enzyme’s DNA as well as the improper regulation of its activity can cause disease.  One 
such disease, neutropenia, occurs when the number of white blood cells circulating in the 
bloodstream is too low to fight off infection (Horwitz, Duan et al. 2007).  Naturally 
occurring HNE works without the use of its C-terminal peptide which is cleaved at some 
point during its activation (see Figure 1).  
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 Figure 1:  Active HNE sequence with full C-terminus.  Signal peptidase removes the 
signal peptide that directs the protein to the endoplasmic reticulum.  DPP-I removes 
the pro-peptide (SE) to activate HNE and cleavage by the unknown protease does 
not occur in neutropenia. 
 
It is thought that if HNE is mutated at a specific position on its C-terminus then the HNE 
is kept from moving out of the neutrophils.  Some research has shown that several types 
of neutropenia are caused by the mutation of neutrophil elastase found in the cytoplasmic 
granules of neutrophils.  Whether the protease becomes membrane bound or not affects 
the type of neutropenia that affects the body (Benson, 2003).  For one type of 
neutropenia, cyclical hematopoiesis, the mutation of ELA2 acts to “prevent membrane 
localization of neutrophil elastase” (Benson, 2003).  Furthermore, the chromosome that 
has been isolated to be the most likely location of mutation of ELA2 is the 19p13.3 
chromosome (Ancliff, 2001).  For mutations of ELA2 (which encodes neutrophil 
elastase) that cause severe congenital neutropenia (SCN), however, the protein becomes 
membrane bound and unable to move outside of the neutrophil (Ancliff, 2001).  While 
the degree to which membrane bound HNE effects the life of the neutrophil and the 
mechanism by which the neutrophil dies is unknown, the presence of membrane bound 
Klimecki 5 
 
HNE has been seen in specific variations of the disease.  Additionally, failure to control 
the activity of HNE released from short-lived neutrophils can prove destructive to the 
body’s tissues, causing disease.  Pulmonary emphysema is thought to be caused when 
components in cigarette smoke, called oxidants, inactivate the blood protein called alpha-
1 antitrypsin, which is the primary inhibitor of HNE in the blood.  This protein acts as an 
inhibitor of HNE, therefore when the inhibitor itself is genetically deficient or damaged 
by oxidation, active HNE is free to wreak havoc on healthy tissues (Laurell and Eriksson 
1965).  
 
The study of HNE would be greatly facilitated by stable expression of the 
recombinant enzyme, which would eliminate the hazards associated with isolating the 
enzyme from human tissues and allow for site-directed mutagenesis studies.  For 
example, natural HNE is missing a C-terminal peptide that, if not removed, results in 
neutropenia.  Recombinant HNE would allow production of HNE with this C-terminal 
extension so its role in neutropenia could be studied further, and full-length HNE could 
be used to study this processing event. 
 
The yeast K. lactis was first studied as a medium for heterologous protein 
expression (Swinkels 1993) and has been used to express a number of recombinant 
proteins (van Ooyen, Dekker et al. 2006).  In addition to being easily manipulated 
genetically and having a “fully sequenced genome” (Dujon 2004), another advantage of 
K. lactis is that correctly folded proteins are secreted into the culture media when fused 
with the alpha mating factor (Colussi 2005).  Yeast, however, have a different preference 
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for codon usage than do mammals (see Figure 2), so the HNE gene was commercially 
synthesized (MrGene) to optimize codon usage for expression in yeasts.   
 
 
Figure 2:  Yeast prefer a different codon usage then do mammals.  The HNE gene 
was thus codon optimized for its use in K. lactis cells. 
 
PCR was used to engineer the HNE gene downstream of the gene for eGFP 
(enhanced green fluorescent protein) with an intervening enterokinase (D4K) cleavage 
site.  This DNA construct (eGFP-D4K-HNE) was cloned into the Kluyveromyces lactis 
(K. lactis) pKLAC1 vector, downstream of the alpha mating factor.  Sequencing 
confirmed the correct construction of the pKLAC1-eGFP-D4K-HNE vector (see Figure 
3).   
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 Figure 3:  The vector map of pKLAC1-eGFP-D4K-HNE. 
 
Chemically competent GG799 cells (a strain of K. lactis) were transformed with the 
linearized pKLAC1-eGFP-D4K-HNE vector.  The GG799 cell line was chosen because 
of its availability in a commercial kit from New England Biolabs (van Ooyen 2006).  
Theoretically, the gene of interest integrates into the yeast genome via sequences in 
pKLAC1 that are homologous with the LAC4 gene under control of the LAC4 promotor, 
which is activated by galactose utilization.  The Kex2 protease cleaves the alpha mating 
factor from the fusion protein as it passes through the Golgi prior to secretion of the 
eGFP-D4K-HNE fusion.  Additionally, acetamide selection was chosen because “K. 
lactis cells have a limited ability to process acetamide” (van Ooyen 2006) as a nitrogen 
source.  The pKLAC1 vector, however, contains the Aspergillus nidulans gene 
acetamidase (amdS) that codes for a protein that allows only transformants to grow on 
plates with acetamide as the sole nitrogen source.  Thus, when acetamide is incorporated 
into nitrogen-free growth plates, non-transformed cells will die (Read 2007). 
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Objective 
 Once a sequenced DNA vector resembling pKLAC1-eGFP-D4K-HNE was 
constructed and verified through sequencing, the vector was linearized and inserted into 
the K. lactis yeast system GG799.  The vector is “targeted to insert into the promoter 
region of the LAC4 chromosomal locus” (Read 2007).  Transformed cells were grown on 
agar media containing only acetamide as a nitrogen source.  This selection method is not 
as ideal as antibiotic selection because the non-transformed K. lactis has low levels of 
endogenous acetamidase.  However positive transformants grow much better on 
acetamide plates and after about five days the transformed colonies are large enough to 
pick and re-plate. 
 
Materials & Methods 
pKLAC1 Vector and eGFP-D4K-HNE Insert.  
The pKLAC1 vector and the eGFP PCR DNA were cut with BglII and XhoI and 
gel purified.  The eGFP was then ligated into the pKLAC1 vector.  The D4K-HNE gene 
was synthesized commercially with the proper restriction sites on either side of the gene.  
The pKLAC1-eGFP vector was then cut at the BgIII and the KpnI sites, and the D4K-
HNE was ligated into the vector. The full vector (eGFP-D4K-HNE) was then 
transformed into E. coli, and transformants were selected on LB agar plates with 
Carbenicillin.  Positive growth colonies were detected via colony PCR using primers 
specific for the PCR insert.  Sequencing confirmed that the eGFP-D4K-HNE DNA 
sequence was correct and in frame with the vector’s Alpha mating factor start codon (see 
Figure 3).  
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Figure 3:  HNE vector construct downstream of the Alpha Mating Factor. 
 
Linearization of pKLAC1 vector 
 Following a restriction digest protocol from Fermentas, the restriction enzyme 
SacII was chosen to linearize the pKLAC1 vector for transformation.  The SacII 
restriction sites are situated on either side of the insert of interest.  This positioning allows 
for the full insert to remain intact upon linearization.  Both the pKLAC1-eGFP and the 
pKLAC1-eGFP-HNE vectors were linearized.  The concentration of the pKLAC1-eGFP-
HNE vector to begin with was 957 µg/ml, and about 10 µg were cut in a total volume of 
20 µl.  Added to 10 µl of DNA was 1 µl of SacII enzyme, 2 µl of buffer, and 7 µl of 
sterile water.  The pKLAC1-eGFP vector was at a starting concentration of 348.5 µg /ml.  
Again 10 µg of DNA was cut.  Added to 28 µl of DNA was 1 µl of SacII enzyme, 2 µl of 
buffer, and 9 µl of sterile water to bring the reaction volume up to 40 µl.  Each reaction 
mixture was incubated at 37°C for one hour followed by a heat inactivation at 65°C for 
twenty minutes.  Cut samples were then placed in the refrigerator for storage.   
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Competency and Transformation of YAP-3 and YPS-7 cells 
 When research was begun, one goal was to find or create a protocol that made 
protease deficient YAP-3 and YPS-7 K. lactis cells competent and able to take up the 
target DNA.  Several months were spent trying different procedures from various papers 
and publications in order to make some progress on this path.  In the end, however, none 
of the attempts successfully achieved positive transformants.  Briefly, a few of the most 
promising procedures follow. 
 
Zymo Method 
 A competency/transformation kit was purchased from Zymo Research.  This kit is 
one type of universal transformation kit in which Zymo provides certain solutions, 
numbered one through three, that aid in both the chemical competency and the chemical 
transformation of certain yeast cells.  The protocol included in the kit was followed.  To 
start, a 10 ml YPD culture of both YAP-3 and YPS-7 cells was shaken overnight.  A 1:10 
dilution was performed the next morning, and the cultures were allowed to continue 
shaking at 30°C for four hours.  Once the O.D. of each culture reached between 0.8-1.0, 
the cells were centrifuged at 5000 x g for four minutes.  The cells were resuspended in 10 
ml of EZ 1 solution, and the centrifugation was repeated.  Finally, the cells were 
resuspended in 1 ml of EZ 2 solution to complete the competency procedure.  Aliquots of 
500 μl were made, and the cells were stored at -80°C for future use. 
 
 To begin the transformation procedure, frozen competent cells were thawed on 
ice.  Next, 50 μl of competent cells was mixed with 2 μg of DNA.  Two cell mixtures 
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were made for each cell line.  One mixture of YPS-7 cells was mixed with the pKLAC1-
eGFP-HNE vector and another with the pKLAC1-eGFP vector.  The same procedure was 
performed on the YAP-3 cells.  Added to each mixture was 500 μl of EZ 3 solution.  
Each mixture was then incubated at 30°C for 45 minutes while vortexing each cell 
mixture every 15 minutes.  After the incubation, 100 μl of each transformed cell mixture 
was spread on YCB + 5mM Acetamide + 50 μg/ml Ampicillin plates and placed at 30°C 
for growth.  Also plated was 50 μl of competent cells that had not been transformed.  This 
plate served as a negative control.  After several days no growth was seen on any plates.   
 
Electroporation 
 Several papers were studied in order to come up with a suitable method for 
electroporation.  The main concern was the machine used and the parameters that it 
allowed.  Starting with a concentration of about 4 µg of DNA per 10 ml, combined with 
50 µl of cells was 1 µl of DNA.  Several different mixtures using different media were 
carried out at once: 
YAP-3 cells in YED:            YAP-3 cells in YPD: 
1. Cells only      1.  Cells only 
2. pKLAC1-eGFP     2.  pKLAC1-eGFP 
3. pKLAC1-eGFP-HNE       3.  pKLAC1-eGFP-HNE 
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YPS-7 cells in WM9:                                                    YPS-7 cells in YPD: 
1. Cells only      1.  Cells only 
2. pKLAC1-eGFP     2.  pKLAC1-eGFP 
3. pKLAC1-eGFP-HNE                                                 3.  pKLAC1-eGFP-HNE       
 
 
The DNA and cells were first combined in PCR tubes and incubated on ice for 15 
minutes.  Each reaction mixture was then transferred to 0.2 cm cuvettes.  The reaction 
conditions were as follows: R=129 ohms, C=40 µF (fixed by machine), and V=1.1 kV.  
In some electroporation procedures the voltage was kept at 1 kV.  The 0.1 increase was in 
the hopes of getting more effective transformations.  The time constant for all mixtures 
ranged from 4.5 to 4.8 ms.  After each sample was electroporated, 500 µl of YPD and 
500 µl of 1M Sorbitol were added to each tube.  The entire 1 ml sample was then 
transferred to an Eppendorf tube, and all samples were incubated on ice for 15 minutes 
and then shaken at 225 r.p.m. and 30°C for one hour.  Possible transformants were then 
plated on YCB + 5 mM Acetamide plates + 50 µg/ml Carbenicillin and left at room 
temperature to grow.  YCB stands for yeast carbonbase and is essentially media that 
contains glucose, vitamins, and minerals but no viable nitrogen source.  No transformants 
were seen after several days of growth (Sanchez 1993).  
 
Single Stranded Carrier DNA 
 A culture of wild type YAP-3 and a culture of YPS-7 cells were begun by 
inoculating 25ml of 2X-YPD with a sample of each cell type.  These samples were 
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shaken overnight at 30°C.  The following morning, the density of each culture was 
checked, and a 1:100 dilution was performed to bring the O.D. of the cultures to around 
0.1.  The cultures were again placed in the incubator at 30°C with shaking for several 
hours.  The O.D. of each culture was continually checked throughout the day, and the 
cells were harvested when they reached an O.D. of between 0.8 – 1.0.   
 
Then, the carrier DNA was placed in a boiling water bath for five minutes to 
allow for the DNA to denature.  The sample was then immediately placed in an ice water 
bath.  Calf Thymus double stranded carrier DNA at a concentration of 1.6mg/ml was 
obtained from Dr. Musich.  Additionally, 2ml of each culture sample was harvested and 
pelleted at 13,000 r.p.m. for 30 seconds.  The supernatant was discarded and a total 
volume of Transformation Mix (T Mix) was then added.  The T mix included the 
following, added in this order: 240μl of polyethylene glycol 3350 (50%), 36μl 
Lithium acetate (1M), 50μl of boiled salmon sperm carrier DNA, 2μl of pKLAC1-GFP-
HNE vector, and finally 32μl of sterile water.  For the control, the T mix included: 240 μl 
of polyethylene glycol 3350 (50%), 36 μl lithium acetate (1M), 50 μl of boiled carrier 
DNA, 4 μl of pKLAC1-GFP vector, and finally 30 μl of sterile water.  Each reaction 
mixture ended with a total volume of 360 μl.  After the T Mix was added, each mixture 
was placed in a 42°C water bath for two hours.  Once the two hour incubation was 
complete, the cells were pelleted at 13,000 r.p.m. for 30 seconds, and then resuspended in 
1ml sterile water.  From this, 100 μl of cells was plated onto YCB + 5mM Acetamide + 
50mg/ml Ampicillin plates and placed at 30°C to induce growth.  No growth was seen 
(Geitz 2007). 
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 Transformation of GG799 K. lactis cells 
 To begin the transformation process, the pKLAC1-eGFP-HNE vector had to be 
linearized.  A multiple cloning site was also present within the pKLAC1 vector in a 
position that allowed our target gene to be sandwiched within the LAC4 promoter upon 
transformation.  This “linear expression cassette…integrates into the promoter region of 
the LAC4 locus of the K. lactis chromosome upon its introduction into K. lactis cells” 
(Colussi 2005).   
 
 After the pKLAC1 vector was linearized, a tube of competent GG799 cells from 
New England Biolabs was thawed on ice.  Aliquoted out into three tubes was 50 μl of 
cells to which was added 155 μl of NEB Yeast Transformation Reagent.  Each tube was 
shaken.  Next, 1 μg of DNA was added to each tube.  To the first tube, 1 μg of pKLAC1-
eGFP was added and to the second tube, 1 μg of pKLAC1-eGFP-HNE was added.  The 
third tube of cells was used as a negative control to which no DNA was added.   
 
 The mixture was incubated at 30°C for 30 minutes.  After this, the cell mixtures 
were heat shocked by incubation at 37°C for one hour.  The cells were then pelleted by 
microcentrifugation at 7000 r.p.m. for two minutes, and the supernatant was discarded.  
The pellet was resuspended in 1 ml of sterile deionized water, and the cells were then 
repelleted by microcentrifugation at 7000 r.p.m. for two minutes.  The supernatant was 
again discarded.  Again the pellet was resuspended, but this time in 1 ml of YPD, and the 
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entire cell mixture was transferred to a sterile culture tube.  The culture tubes were 
incubated with shaking at 30°C for 30 minutes.   
 
 After the incubation period, the mixture was transferred to 1.5 ml microcentrifuge 
tubes, and the mixture was again repelleted by microcentrifugation at 7000 r.p.m. for two 
minutes.  Once pelleted, the cells were washed twice in 1 ml sterile deionized water 
followed by microcentrifugation.  Finally, the cell pellet was resuspended in 100 μl of 
sterile deionized water.  From this, 80 μl of solution was plated on YCB + 5mM 
Acetamide + 50 μg/ml Cipro and Ampicillin.  The remaining 20 μl was plated onto YPD 
plates as a positive control.  Each plate was placed at 30°C for growth.  Growth took 
several days.  Once adequate growth had occurred, colonies were picked and transferred 
to YPGal plates.  These plates contained galactose which theoretically activates the HNE.  
Each colony was then subjugated to whole-cell PCR to see if the cells did, in fact, contain 
the insert of interest. 
 
Whole-Cell PCR 
 From each colony on the YPGal plates, a small sample was taken and 
resuspended in 25 μl of 1 M Sorbitol containing 2 mg/ml Lyticase.  The Lyticase simply 
breaks the cells apart so that the DNA inside can be reached.  Each sample was mixed by 
vortexing and placed in a 37°C water bath for one hour.  Next, the samples were lysed in 
a thermocycler at 96°C for 10 minutes.  Then, a colony PCR was conducted.  In addition 
to the 25 μl DNA template, which is genomic DNA obtained from the Lyticase treated 
cells, 10 μl of Primers 1 and 2 were added, along with 5 μl of Protease free water, and 50 
Klimecki 16 
 
μl of reaction mix (GoTaq).  The samples were placed in a standard PCR thermocycle 
heat block, and a colony PCR reaction was run. 
 
 Once the PCR reaction was complete, a FlashGel was run on the samples.  The 
FlashGel is an easy and fast way of telling whether the target DNA was isolated and 
replicated by the PCR.  In the wells, 4 μl of sample were combined with 1 μl of the 
FlashGel loading dye.  The gel was then run for seven minutes.  No bands corresponding 
to an insert were seen in any of the samples.   
 
Results 
In the past, the yeast Kluyveromyces lactis was used to express many recombinant 
proteins because of its ability to secrete correctly folded proteins into media (Swaim 
2008).  In order to bioengineer the correct DNA sequence for the HNE construct, 
however, the HNE sequence had to be commercially synthesized because yeast prefer 
different codon usages than do mammals.  This technique is known as codon 
optimization.  The company Mr. Gene was used to codon optimize the gene for human 
neutrophil elastase.  The optimized DNA is known as cDNA because it is an artificial 
gene that contains no introns that native genes contain.  These introns are removed via 
mRNA splicing in native genes.  Therefore, the cDNA transcribes directly into the 
mature mRNA.  Once the correct sequence was made, it was fused with the sequence for 
enhanced green fluorescent protein (eGFP).  Linking the eGFP and HNE sequences is an 
enterokinase (D4K) cleavage site that once activated could be targeted to activate HNE 
into the media.  This DNA construct (eGFP-D4K-HNE) was then fused downstream of 
Klimecki 17 
 
the alpha mating factor in the K. lactis pKLAC1 vector, because when secreted, the alpha 
mating factor carries the attached proteins into the media.  This vector was then 
sequenced in order to confirm the correct DNA sequence.   
 
Chemically competent GG799 cell strains of K. lactis were then transformed with 
the pKLAC1-eGFP-D4K-HNE vector using a procedure from NEB.  Theoretically, the 
gene is able to integrate into the yeast’s genome via homologous regions within the 
LAC4 promoter which is a transcription promoter for beta-galactosidase (Colussi 2005).  
The sugar galactose activates the HNE.  For selection, acetamide was incorporated into 
the YCB agar plates.  Untransformed K. lactis cells are unable to use acetamide and die, 
however, the pKLAC1 vector also contains the gene Aspergillus nidulans acetamidase 
(amdS) which codes for a protein that allows transformants to convert the acetamide into 
a viable nitrogen source, so only transformed cells live.  After attempting the NEB 
transformation multiple times, no transformants were seen.  Communication between this 
lab and experts at NEB who specialized in the K. lactis system was helpful in that the 
experts provided invaluable advice on the transformation protocol and the mistakes that 
may have been made.  Despite the help, no positive transformants were ever grown. 
 
Discussion 
The goal of this research was to be able to produce stable, active human 
neutrophil elastase using the K. lactis yeast system.  To begin, protease deficient YAP-3 
and YPS-7 cell lines were used in an attempt to transform them with our target DNA 
sequence (alpha mating factor-eGFP-D4K-HNE).  Protease deficient cell lines were used 
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because it was initially thought that there would be less of a chance that the target 
enzyme (HNE) would be severed and thus degraded by proteases present in the secretory 
pathway.  This process proved difficult for two reasons.  One, no method attempted was 
able to provide competent YAP-3 and YPS-7 cells to start which meant that no protocol 
was successful in producing positive transformants, our second problem.  Everything 
from electroporation techniques to simple chemical techniques were attempted, however 
none produced positive results.  Also, it was shown that if casamino acids were added to 
the growth media for these cells, proteases present in the secretory pathway had enough 
amino acids to consume and would presumably not affect the enzyme in question.  In 
addition to this revelation was the knowledge that the selection on acetamide plates was 
not as stringent as antibiotic selection.   
 
For selection, our vector contained a gene for acetamidase which in theory 
allowed only true transformants to be able to grow on the YCB + Acetamide plates.  To 
grow, the acetamidase gene allows transformants to utilize the acetamide present in the 
plates and convert it into a viable nitrogen source for growth.  All other cells would 
theoretically die as they had no way to obtain the necessary nitrogen.  Growth was seen 
on the plates, however, even when the cells that had not undergone transformation were 
plated on them.  Upon speaking with an expert on the K. lactis system, however, it was 
discovered that wild type K. lactis strains contain a native acetamidase gene which allows 
even untransformed cells to utilize the acetamide in the agar plates.  These cells, 
however, have a low basal level of expression so that growth is not seen until several 
days after plating.  Positive transformants grow faster too because they can metabolize 
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acetamide much more quickly.  A background lawn of cells was expected but not 
individual colonies on these negative controls (see Figure 4). 
 
 
Figure 4:  The top plate shows what the colonies from a successful transformation 
look like.  The bottom plate shows a lawn of cells which means the transformation 
failed. 
 
Furthermore, cells did grow on the plates where transformants should have been 
seen.  Colonies selected on acetamide plates were transferred to YCB galactose plates to 
induce expression.  Once viewed under the fluorescent microscope, however, the cells 
did not glow green meaning that the cells were not positive transformants.  In effect, the 
big question became how are the cells able to grow on the acetamide plates even without 
the acetamidase gene?  One possibility was the fact that in many of the protocols 
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attempted, the cells were incubated in YPD media directly before the plating step.  
Without a wash step in sterile deionized water, it was thought that perhaps the media had 
provided enough nitrogen for cells to begin to grow on the plates even without the ability 
to convert acetamide into nitrogen.  While the use of YAP-3 and YPS-7 cells was 
ultimately abandoned, the issue of non-transformants growing on the acetamide plates 
persisted.  Because the YAP-3 and the YPS-7 cell lines proved difficult to make 
competent as well as to transform, another K. lactis cell line was chosen, GG799.  These 
cells were not protease deficient but were purchased chemically competent.  Following 
the NEB procedure for transformation, however, proved fruitless as the supposed 
transformed cells did not, in fact, contain our DNA of interest.  To determine this, 
however, a new method of identification had to be found.  The use of the fluorescent 
microscope had proved subjective in the past because the shade of green of positive 
transformants varied so much.  Therefore, human error was a great factor in determining 
whether or not the cells contained the vector of interest.  Instead PCR was used to 
amplify the insert, but no insert was seen after the PCR results were run on an agarose gel 
(1.2% Lonza FlashGel). 
 
Recently, a paper was found that discussed the secretion results of different 
proteins all fused with the α-mating factor.  After much experimentation, these 
researchers discovered that the α-factor was unable to secrete when attached to green 
fluorescent protein (Kjaerulff 2005).  Furthermore, with more investigation it was also 
found that the Kex2 site, which was placed between the alpha mating factor and the 
eGFP, showed a prevalence for cutting at locations within an amino acid sequence that 
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contained either the amino acids lysine and arginine beside each other or two arginines 
side by side (Bevan et al., 1998).  Because the original amino acid sequence of HNE 
contained approximately four of these double arginine sites, it was reasonably thought 
that the Kex2 might be fragmenting the HNE as it traffics through the Golgi. 
 
To correct for these measures, new inserts were codon optimized and 
commercially synthesized (Genscript).  To begin, the pKLAC1 vector was modified by 
replacing the alpha mating factor it originally contained with an optimized insert 
containing alpha mating factor linked with rubredoxin and six histidines (Rub-6His).  The 
codon optimized insert D4K-HNE was then inserted into the multiple cloning site of this 
new vector (named pKaR).  Before being commercially synthesized, however, the three 
dimensional figure of HNE was studied and the double arginine sites were found and 
modified.  The goal was to substitute other amino acids in for an arginine when two 
arginines appeared together.  The hydrogen bonding of the protein had to be taken into 
consideration, however, so only those residues that did not participate extensively in the 
hydrogen bonding of the protein were changed.  Furthermore, similar amino acids 
replaced the arginines such as asparagine which has a neutral charge but can still 
participate in hydrogen bonding to some degree.  The replacement of these arginines with 
amino acids such as asparagine also lowered the isoelectric point of the protein, which 
will most likely aid in its production.   
 
With the new construct (pKaR-HNE), K. lactis competent GG799 cells were 
transformed by the protocol from New England Biolabs.  Frozen cells were thawed on ice 
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and mixed with DNA and NEB Yeast Transformation Reagent as per NEB’s protocol.  
At the end of the protocol, the cells were plated onto YCB + 5mM Acetamide plates, and 
after a few days of growing at 30°C, positive colonies were seen.  A few selected 
colonies were used to inoculate 2ml WM9Gal media.  Theses cultures were used to 
extract the genomic DNA. 
 
Acid glass beads (0.5mm diameter) were used along with solutions of 
Phenol/Chloroform/Isoamyl alcohol to extract the genomic DNA from the transformed 
cells.  Once the DNA was extracted, agarose gels were run on the samples to test the 
integrity of the DNA.  While there was some fragmentation, there was in-tact genomic 
DNA.  Now a colony PCR will be run on the genomic DNA to ensure that the 
transformed cells do in fact contain the gene of interest. 
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